Related Experiment Video
Updated: Jun 19, 2026
08:17
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
Metachromatic leukodystrophy: a scoring system for brain MR imaging observations.
1Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. feichler@partners.org
AJNR. American Journal of Neuroradiology
|October 3, 2009
Summary
A new scoring method quantifies brain involvement in metachromatic leukodystrophy (MLD) using MR imaging. This tool aids in assessing disease progression and severity in MLD patients.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Metachromatic leukodystrophy (MLD) is a severe demyelinating disease.
- Novel therapeutic strategies for MLD are under investigation.
- Quantifying disease burden is crucial for treatment evaluation.
Purpose of the Study:
- To develop and validate a quantitative MR imaging scoring system for brain involvement in MLD.
- To assess the reliability of the proposed scoring method.
Main Methods:
- Review of 34 brain MR images from 28 MLD patients (late infantile, juvenile, adult).
- Experienced neuroradiologists and neurologists applied a visual scoring system (0-34 points) based on white matter lesions and atrophy.
- Readers were blinded to clinical data.
Main Results:
- High inter-rater reliability (0.988) was achieved with scores differing by a maximum of 2 points.
- Confluent white matter hyperintensities were observed in 33 of 34 MR images.
- Serial imaging in 6 patients demonstrated disease progression in 3 and stability in 3, correlating with initial scores.
Conclusions:
- The developed MR imaging severity scoring method effectively measures brain involvement in MLD.
- This quantitative tool can aid in monitoring disease progression and treatment response in MLD.
